The Food and Drug Administration (FDA) has approved the handheld ultrasound device for use by primary care providers (PCPs). The device is indicated for ultrasound echo imaging, measurement, and analysis of the human body for general clinical applications including musculoskeletal, vascular, small parts (breast, thyroid), and lung imaging. One of them works in tandem with an app that displays the images for analysis on both tablets and smartphones.
The device, which weighs just 13 ounces, has a rechargeable, lithium ion-battery (3-hour continuous scanning battery life), WiFi connectivity and 3G/LTE cellular capability. It also supports medical imaging protocols including DICOM (Digital Imaging and Communications in Medicine) and PACS (Picture Archiving and Communication System). Since its finding in 2014, the Vancouver-based startup has specialized in developing a handheld…
